LRRC37B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.64079860809352E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.22302168392707E-12 |
Normal-vs-Stage2 |
4.36510000001444E-06 |
Normal-vs-Stage3 |
7.54310000000702E-05 |
Normal-vs-Stage4 |
4.476900E-03 |
Stage1-vs-Stage2 |
5.969800E-01 |
Stage1-vs-Stage3 |
4.505800E-01 |
Stage1-vs-Stage4 |
8.086800E-01 |
Stage2-vs-Stage3 |
2.904000E-01 |
Stage2-vs-Stage4 |
5.387200E-01 |
Stage3-vs-Stage4 |
8.091600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.49880108324396E-14 |
Normal-vs-AfricanAmerican |
7.16049997073753E-10 |
Normal-vs-Asian |
3.362100E-02 |
Caucasian-vs-AfricanAmerican |
7.385600E-01 |
Caucasian-vs-Asian |
9.040400E-01 |
AfricanAmerican-vs-Asian |
8.079400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.73094871769308E-12 |
Normal-vs-Female |
1.93145499594038E-12 |
Male-vs-Female |
1.687160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.02580000049812E-07 |
Normal-vs-Extreme_Weight |
2.27210028569402E-10 |
Normal-vs-Obese |
3.21699999972225E-10 |
Normal-vs-Extreme_Obese |
6.423400E-03 |
Normal_Weight-vs-Extreme_Weight |
9.556400E-01 |
Normal_Weight-vs-Obese |
7.490600E-01 |
Normal_Weight-vs-Extreme_Obese |
9.066200E-01 |
Extreme_Weight-vs-Obese |
6.661600E-01 |
Extreme_Weight-vs-Extreme_Obese |
9.300800E-01 |
Obese-vs-Extreme_Obese |
7.554800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.7419000000023E-05 |
Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
Normal-vs-Age(61-80Yrs) |
1.05739972333652E-10 |
Normal-vs-Age(81-100Yrs) |
3.517600E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.370800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.433700E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.691800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.259770E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.854000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.938600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
Normal-VS-Type2 PRCC |
1.72303999999013E-05 |
Normal-VS-KIRP CIMP |
1.107550E-02 |
Normal-VS-Unclassified PRCC |
4.37620000015571E-07 |
Type1 PRCC-VS-Type2 PRCC |
4.63789995297503E-09 |
Type1 PRCC-VS-KIRP CIMP |
5.254400E-01 |
Type1 PRCC-VS-Unclassified PRCC |
2.140600E-01 |
Type2 PRCC-VS-KIRP CIMP |
5.780000E-02 |
Type2 PRCC-VS-Unclassified PRCC |
5.958700E-03 |
KIRP CIMP-VS-Unclassified PRCC |
9.421400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.75430000818267E-09 |
Normal-vs-N1 |
3.9714000000024E-05 |
Normal-vs-N2 |
2.549700E-02 |
N0-vs-N1 |
3.360600E-01 |
N0-vs-N2 |
4.726400E-01 |
N1-vs-N2 |
3.579800E-01 |
|
|